Jilin University

About: Jilin University is a education organization based out in Changchun, China. It is known for research contribution in the topics: Catalysis & Apoptosis. The organization has 101453 authors who have published 88966 publications receiving 1444456 citations. The organization is also known as: Jílín Dàxué.

Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The BRIGHT Randomized Clinical Trial

Abstract: Importance The safety and efficacy of bivalirudin compared with heparin with or without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI) are uncertain. Objective To determine if bivalirudin is superior to heparin alone and to heparin plus tirofiban during primary PCI. Design, Setting, and Participants Multicenter, open-label trial involving 2194 patients with AMI undergoing primary PCI at 82 centers in China between August 2012 and June 2013. Interventions Patients were randomly assigned to receive bivalirudin with a post-PCI infusion (n = 735), heparin alone (n = 729), or heparin plus tirofiban with a post-PCI infusion (n = 730). Among patients treated with bivalirudin, a postprocedure 1.75 mg/kg/h infusion was administered for a median of 180 minutes (IQR, 148-240 minutes). Main Outcomes and Measures The primary end point was 30-day net adverse clinical events, a composite of major adverse cardiac or cerebral events (all-cause death, reinfarction, ischemia-driven target vessel revascularization, or stroke) or bleeding. Additional prespecified safety end points included the rates of acquired thrombocytopenia at 30 days, and stent thrombosis at 30 days and 1 year. Results Net adverse clinical events at 30 days occurred in 65 patients (8.8%) of 735 who were treated with bivalirudin compared with 96 patients (13.2%) of 729 treated with heparin (relative risk [RR], 0.67; 95% CI, 0.50-0.90; difference, −4.3%, 95% CI, −7.5% to −1.1%; P = .008); and 124 patients (17.0%) of 730 treated with heparin plus tirofiban (RR for bivalirudin vs heparin plus tirofiban, 0.52; 95% CI, 0.39-0.69; difference, −8.1%, 95% CI, −11.6% to −4.7%; P P P = .74), stent thrombosis (0.6% vs 0.9% vs 0.7%, respectively, P = .77), acquired thrombocytopenia (0.1% vs 0.7% vs 1.1%; P = .07), or in acute ( Conclusions and Relevance Among patients with AMI undergoing primary PCI, the use of bivalirudin with a median 3-hour postprocedure PCI-dose infusion resulted in a decrease in net adverse clinical events compared with both heparin alone and heparin plus tirofiban. This finding was primarily due to a reduction in bleeding events with bivalirudin, without significant differences in major adverse cardiac or cerebral events or stent thrombosis. Trial Registration clinicaltrials.gov Identifier:NCT01696110

Deep Red Emissive Carbonized Polymer Dots with Unprecedented Narrow Full Width at Half Maximum

Abstract: Development of high-performance carbon dots (CDs) with emission wavelength longer than 660 nm (deep red emission) is critical in deep-tissue bioimaging, yet it is still a major challenge to obtain CDs with both narrow full width at half maximum (FWHM) and high deep red/near-infrared emission yield. Here, deep red emissive carbonized polymer dots (CPDs) with unprecedented FWHM of 20 nm are synthesized. The purified CPDs in dimethyl sulfoxide (DMSO) solution possess quantum yield (QY) as high as 59% under 413 nm excitation, as well as recorded QY of 31% under 660 nm excitation in the deep red fluorescent window. Detailed characterizations identify that CPDs have unique polymer characteristics, consisting of carbon cores and the shells of polymer chains, and π conjugated system formed with N heterocycles and aromatic rings governs the single photoluminescence (PL) center, which is responsible for high QY in deep red emissive CPDs with narrow FWHM. The CPDs exhibit strong absorption and emission in the deep red light region, low toxicity, and good biocompatibility, making them an efficient probe for both one-photon and two-photon bioimaging. CPDs are rapidly excreted via the kidney system and hepatobiliary system.

Raman Investigation of Nanosized TiO2: Effect of Crystallite Size and Quantum Confinement

Abstract: The influence of the TiO2 particle size on the enhanced Raman spectroscopy properties was systematically investigated on the nanometer-size scale. We report on the enhanced Raman spectrum of 4-mercaptobenzoic acid adsorbed on TiO2 nanoparticles. The results presented in this study highlight the major findings that the intensities of both the molecular lines and the phonon modes of TiO2 are strongly size-dependent. The TiO2 crystallite size estimated using the Scherrer equation varied from 6.8 to 14.2 nm; as a function of crystal size, a large increase in intensity is observed, with a maximum near 10.9 nm and a subsequent decline at larger sizes. Moreover, we have investigated quantum confinement effects between TiO2 and the adsorbed molecules and attribute this to a charge-transfer resonance, which is responsible for the Raman enhancement.

N-rich zeolite-like metal–organic framework with sodalite topology: high CO2 uptake, selective gas adsorption and efficient drug delivery

Abstract: A novel zeolite-like metal–organic framework (ZMOF) with sodalite topology, [Zn(HL)]·DMA (IFMC-1, L = 4,5-di(1H-tetrazol-5-yl)-2H-1,2,3-triazole and IFMC = Institute of Functional Material Chemistry), was solvothermally synthesized based on an N-rich aromatic ligand without a NH2 group. It exhibits high CO2 uptake and selective CO2/N2 adsorption capacity. For the first time, we investigated the influence of a large number of uncoordinated nitrogen atoms from aromatic rings for CO2 adsorption in ZMOFs. This result reveals that the high percentage of open N-donor sites leads to the high uptake capacity for CO2, even in the absence of any NH2 groups and open metal sites. In addition, it also exhibits efficient drug delivery capacity.